Vanda Pharma executive reports initial VNDA holdings
Vanda Pharmaceuticals Inc. executive Christos Vasilios Mihael Polymeropoulos, Senior VP and Medical Director, filed an initial ownership report showing his equity positions in the company.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
3
Rhea-AI Filing Summary
Vanda Pharmaceuticals Inc. executive Christos Vasilios Mihael Polymeropoulos, Senior VP and Medical Director, filed an initial ownership report showing his equity positions in the company. He holds a stock option to buy 61,200 shares of common stock at an exercise price of $7.05 per share, expiring on February 15, 2033. The filing also lists multiple common stock and restricted stock unit (RSU) awards, with time-based vesting schedules running from March 1, 2027 through March 1, 2029, contingent on his continued employment and delivery of vested shares on the first permissible trading day after each vest date.
Insider Trade Summary
6 transactions reported
Mixed
6 txns
Insider
Polymeropoulos Christos Vasilios Mihael
Role
Senior VP, Medical Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 61,200 contracts (Direct);
Common Stock — 386,241 shares (Direct)
Footnotes (5)
- F1. Represents shares of common stock underlying a time-based restricted stock unit award ("RSU"). The RSU will vest in full on March 1, 2027, provided the Reporting Person remains continuously employed by the Issuer through such vesting date. Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement) that occurs on or after the day when the RSUs vest.
- F2. Represents shares of common stock underlying an RSU award. One-half of the RSU will vest on March 1, 2027, and the remaining one-half of the RSU will vest on March 1, 2028, provided the Reporting Person remains continuously employed by the Issuer through each vesting date. Vested shares will be delivered on the First Permissible Trading Day that occurs on or after the day when the RSUs vest.
- F3. Represents shares of common stock underlying an RSU award. The RSU vests as follows: 1/3 will vest on March 1, 2027, 1/3 will vest on March 1, 2028, and the remaining 1/3 will vest on March 1, 2029, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day that occurs on or after the day when the RSUs vest.
- F4. Represents shares of common stock underlying an RSU award. The RSU vests in four (4) equal annual installments with the first annual vest taking place on March 1, 2027, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date. Vested shares will be delivered on the First Permissible Trading Day that occurs on or after the day when the RSUs vest.
- F5. The option vests in equal monthly installments on the 16th day of each month through February 16, 2027, provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date.
Key Figures
Stock option underlying shares: 61,200 shares
Option exercise price: $7.05/share
Option expiration: February 15, 2033
+3 more
6 metrics
Stock option underlying shares
61,200 shares
Right to buy Vanda common stock
Option exercise price
$7.05/share
Exercise price for 61,200-share option
Option expiration
February 15, 2033
Expiration date of stock option position
Common stock holding line
129,791 shares
Total common shares shown in one entry
RSU first vesting date
March 1, 2027
Initial vest date across multiple RSU awards
Final RSU vesting date
March 1, 2029
Last scheduled vesting under described RSU awards
Key Terms
restricted stock unit, Stock Option (Right to Buy), First Permissible Trading Day, continuous employment, +1 more
5 terms
restricted stock unit financial
"Represents shares of common stock underlying a time-based restricted stock unit award ("RSU")."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Stock Option (Right to Buy) financial
"security_title": "Stock Option (Right to Buy)""
First Permissible Trading Day financial
"Vested shares will be delivered on the First Permissible Trading Day (as defined in the RSU Agreement)"
continuous employment financial
"provided the Reporting Person remains continuously employed by the Issuer through such vesting date."
continuous service financial
"provided the Reporting Person provides continuous service to the Issuer through the applicable vesting date."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the VNDA Form 3 filing by Christos Polymeropoulos show?
The Form 3 shows Christos Polymeropoulos’ existing equity holdings in Vanda Pharmaceuticals, including common stock, stock options, and restricted stock units. It establishes his starting ownership position as Senior VP, Medical Director, without detailing any new purchase or sale transactions.
What is the exercise price and expiration date of the VNDA stock option reported?
The stock option reported has an exercise price of $7.05 per share and expires on February 15, 2033. This means he may exercise the option at that price before expiration, subject to the vesting and continuous service conditions described.
What RSU vesting terms are disclosed for Vanda (VNDA) in this Form 3?
The footnotes describe several RSU awards that vest between March 1, 2027 and March 1, 2029. Some vest in a single installment, others in halves or thirds, all requiring continuous employment and delivering shares on the first permissible trading day after vesting.
AI-generated analysis. How Rhea-AI works. Not financial advice.
